Photo by nci from unsplash
Breast cancer is often treated with anthracyclines and HER2 inhibitors, which are well-known cardiotoxic agents. Cancer therapeutics related cardiac dysfunction (CTRCD) has been defined by most guidelines using arbitrary left… Click to show full abstract
Breast cancer is often treated with anthracyclines and HER2 inhibitors, which are well-known cardiotoxic agents. Cancer therapeutics related cardiac dysfunction (CTRCD) has been defined by most guidelines using arbitrary left ventricular ejection fraction (LVEF) cut-off points or decreases. Our
Keywords:
parameters predict;
cancer;
breast cancer;
echocardiographic parameters;
baseline echocardiographic
Journal Title: Journal of the American College of Cardiology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!